Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Asthma
ADR ID BADD_A00365
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.03      Allergic conditions NEC
10.01.03.010      Asthma
22      Respiratory, thoracic and mediastinal disorders
22.03      Bronchial disorders (excl neoplasms)
22.03.01      Bronchospasm and obstruction
22.03.01.002      Asthma
Description A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). [MeSH]
MedDRA Code 10003553
MeSH ID D001249
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Allergic asthma | Asthma | Asthma aggravated | Asthma bronchial | Asthma extrinsic | Asthma NOS | Asthma, unspecified | Asthma, unspecified type, without mention of status asthmaticus | Asthma/bronchitis | Asthmatic | Asthmatic attack | Asthmatic attack induced | Atopic asthma | Br. asthma | Bronchitic asthma | Bronchitis asthmatic | Exacerbation of asthma | Extrinsic asthma | Extrinsic asthma without mention of status asthmaticus | Intrinsic asthma | Intrinsic asthma without mention of status asthmaticus | Asthma chronic | Asthma-like condition | Asthmatic attack atopic | Drug-induced asthma | Cold induced asthma | Neutrophilic asthma | Eosinophilic asthma | Paucigranulocytic asthma | Infection induced asthma | Nocturnal asthma | Seasonal asthma | Bronchial asthma | Thunderstorm asthma | Asthmas | Bronchial Asthma | Asthma, Bronchial
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02443Tiotropium0.002035%
BADD_D02452Icatibant-
BADD_D02464Fingolimod0.008921%
BADD_D02465Aclidinium0.004861%
BADD_D02471Oxygen0.002478%
BADD_D02473Sodium chloride0.000724%
BADD_D02480Alectinib0.000168%
BADD_D02487Baricitinib0.001640%
BADD_D02492Deflazacort0.000175%
BADD_D02504Lorlatinib0.000112%
BADD_D02511Siponimod0.000651%
BADD_D02527Abrocitinib0.000993%
BADD_D02558Gadolinium cation (3+)-
BADD_D02572Migalastat0.004312%
BADD_D02577Oseltamivir acid0.000620%
BADD_D02580Ozanimod0.002580%
The 17th Page    First    Pre   17    Total 17 Pages
ADReCS-Target
ADR Term Drug Name Target